SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.
暂无分享,去创建一个
Ming Yao | Jing Li | Jinjun Li | Lei Liu | Jinjun Li | M. Yao | A. Gu | Mingxia Yan | M. Yan | Tao Yu | Hechun Lin | Tao Yu | Fanglin Zhang | Fang-lin Zhang | He-chun Lin | Jing Li | Lei Liu | Yong-qi Cui | Wei Deng | Aiqin Gu | Yongqi Cui | Wei Deng | Ming-xia Yan
[1] M. Larsen,et al. Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin. , 2014, Journal of proteomics.
[2] T. Yamashita,et al. High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma , 2013, PloS one.
[3] Y. Murakumo,et al. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression , 2010, Pathology international.
[4] Brett Larsen,et al. Label-free quantitative proteomics trends for protein-protein interactions. , 2013, Journal of proteomics.
[5] Claude Négrier,et al. Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. , 2013, Critical reviews in oncology/hematology.
[6] J. Shao,et al. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis , 2012, Journal of Translational Medicine.
[7] Francesca Pentimalli,et al. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery. , 2013, Mass spectrometry reviews.
[8] M. Wilkerson,et al. Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. , 2010, Cancer cell.
[9] Lei Liu,et al. Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion , 2010, BMC Cancer.
[10] Trong Khoa Pham,et al. Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). , 2007, Journal of proteome research.
[11] Jingchu Luo,et al. Secreted protein prediction system combining CJ-SPHMM, TMHMM, and PSORT , 2003, Mammalian Genome.
[12] N. Zolotarjova,et al. Multi-component immunoaffinity subtraction and reversed-phase chromatography of human serum. , 2008, Methods in molecular biology.
[13] T. Lim,et al. iTRAQ Based Quantitative Proteomics Approach Validated the Role of Calcyclin Binding Protein (CacyBP) in Promoting Colorectal Cancer Metastasis* , 2013, Molecular & Cellular Proteomics.
[14] F. Esteva,et al. Serum CD44 levels and overall survival in patients with HER2-positive breast cancer , 2011, Breast Cancer Research and Treatment.
[15] Deepa Naishadham,et al. Cancer statistics for Hispanics/Latinos, 2012 , 2012, CA: a cancer journal for clinicians.
[16] Sean L Seymour,et al. The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S , 2007, Molecular & Cellular Proteomics.
[17] T. Ørntoft,et al. Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors , 2014, Proteomics.
[18] Mårten Fernö,et al. Grading Breast Cancer Tissues Using Molecular Portraits* , 2013, Molecular & Cellular Proteomics.
[19] A. Dirksen,et al. Preoperative staging of lung cancer with combined PET-CT. , 2009, The New England journal of medicine.
[20] K. Rabe,et al. Management of non-small-cell lung cancer: recent developments , 2013, The Lancet.
[21] S. Brunak,et al. SignalP 4.0: discriminating signal peptides from transmembrane regions , 2011, Nature Methods.
[22] Masahide Takahashi,et al. CD109 expression levels in malignant melanoma. , 2010, Journal of dermatological science.
[23] Kelvin H Lee,et al. Shotgun proteomics using the iTRAQ isobaric tags. , 2006, Briefings in functional genomics & proteomics.
[24] Wei Li,et al. Reprogramming- and pluripotency-associated membrane proteins in mouse stem cells revealed by label-free quantitative proteomics. , 2013, Journal of proteomics.
[25] Ludovic C. Gillet,et al. Quantitative measurements of N‐linked glycoproteins in human plasma by SWATH‐MS , 2013, Proteomics.
[26] Ming Yao,et al. Integrative Analyses Identify Osteopontin, LAMB3 and ITGB1 as Critical Pro-Metastatic Genes for Lung Cancer , 2013, PloS one.
[27] Derek C. Radisky,et al. Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109 , 2010, Breast Cancer Research and Treatment.
[28] Paul Dowling,et al. Analysis of acute‐phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer , 2012, International journal of cancer.
[29] F. Bertoni,et al. Syndecan-4 and fibronectin in osteosarcoma , 2012, Pathology.
[30] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[31] Maria P. Pavlou,et al. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology , 2010, Molecular oncology.
[32] S. Hanash,et al. In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding. , 2009, Cancer research.
[33] M. Laakso,et al. An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis. , 2012, Journal of proteomics.
[34] Y. Khew-Goodall,et al. The secretome in cancer progression. , 2013, Biochimica et biophysica acta.
[35] C. Bowler,et al. iTRAQ-based proteomic analysis of the metabolism mechanism associated with silicon response in the marine diatom Thalassiosira pseudonana. , 2014, Journal of proteome research.
[36] Ludovic C. Gillet,et al. Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.
[37] Ioanna Kougioumtzi,et al. Lung cancer surgery: an up to date. , 2013, Journal of thoracic disease.
[38] C. Pilarsky,et al. Laminin, gamma 2 (LAMC2): A Promising New Putative Pancreatic Cancer Biomarker Identified by Proteomic Analysis of Pancreatic Adenocarcinoma Tissues* , 2013, Molecular & Cellular Proteomics.
[39] Dominique Trudel,et al. Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer , 2012, The Journal of Biological Chemistry.
[40] T. Veenstra,et al. Brugia malayi Excreted/Secreted Proteins at the Host/Parasite Interface: Stage- and Gender-Specific Proteomic Profiling , 2009, PLoS neglected tropical diseases.
[41] Xianghuo He,et al. Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC. , 2013, Journal of proteome research.
[42] Swarnlata Saraf,et al. Matrix metalloproteinase enzymes and their naturally derived inhibitors: Novel targets in photocarcinoma therapy , 2014, Ageing Research Reviews.
[43] B. Mroczko,et al. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer , 2010, Clinical and Experimental Medicine.
[44] Jie Zhang,et al. Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis , 2012, BMC Cancer.
[45] B. Liu,et al. Evaluation of three high abundance protein depletion kits for umbilical cord serum proteomics , 2011, Proteome Science.
[46] Ruedi Aebersold,et al. A Serum Protein Profile Predictive of the Resistance to Neoadjuvant Chemotherapy in Advanced Breast Cancers* , 2011, Molecular & Cellular Proteomics.
[47] S. Fulda,et al. G‐Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1 , 2013, The Journal of pathology.
[48] Richard J. Simpson,et al. ExoCarta as a resource for exosomal research , 2012, Journal of extracellular vesicles.
[49] Jason U Tilan,et al. Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing. , 2011, The American journal of pathology.
[50] S. Dao,et al. Automated Mass Spectrometry–Based Functional Assay for the Routine Analysis of the Secretome , 2013, Journal of laboratory automation.
[51] D. Caccia,et al. Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways. , 2011, Journal of proteome research.
[52] M. Salama,et al. Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer. , 2013, Endocrine-related cancer.
[53] Q. Hamid,et al. Differential Roles of CXCL2 and CXCL3 and Their Receptors in Regulating Normal and Asthmatic Airway Smooth Muscle Cell Migration , 2013, The Journal of Immunology.
[54] R. Götz,et al. Disruption of tumor cell adhesion promotes angiogenic switch and progression to micrometastasis in RAF-driven murine lung cancer. , 2007, Cancer cell.
[55] Ludovic C. Gillet,et al. Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system , 2013, Nature Methods.
[56] B. Boyes,et al. Optimization of data-dependent acquisition parameters for coupling high-speed separations with LC-MS/MS for protein identifications. , 2013, Journal of biomolecular techniques : JBT.
[57] A. Vlahou,et al. Secretome proteomics for discovery of cancer biomarkers. , 2010, Journal of proteomics.
[58] Tony Pawson,et al. Mapping differential interactomes by affinity purification coupled with data independent mass spectrometry acquisition , 2013, Nature Methods.
[59] M. Ichihara,et al. Detection of a Soluble Form of CD109 in Serum of CD109 Transgenic and Tumor Xenografted Mice , 2014, PloS one.
[60] C. Bucana,et al. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.